347 related articles for article (PubMed ID: 6365774)
1. Role of the maternal organism in transplacental carcinogenesis.
Alexandrov VA
IARC Sci Publ; 1983; (51):65-79. PubMed ID: 6365774
[TBL] [Abstract][Full Text] [Related]
2. Prenatal and childhood exposure to carcinogenic factors.
Napalkov NP
Cancer Detect Prev; 1986; 9(1-2):1-7. PubMed ID: 3731185
[TBL] [Abstract][Full Text] [Related]
3. Transplacental carcinogens.
Barnes AB
Compr Ther; 1978 Mar; 4(3):34-7. PubMed ID: 630826
[TBL] [Abstract][Full Text] [Related]
4. Some results and prospects of transplacental carcinogenesis studies.
Alexandrov VA
Neoplasma; 1976; 23(3):285-99. PubMed ID: 822360
[TBL] [Abstract][Full Text] [Related]
5. Perinatal carcinogenesis: biologic curiosity or practical necessity?
Clayson DB
Natl Cancer Inst Monogr; 1979 May; (51):235-8. PubMed ID: 481576
[TBL] [Abstract][Full Text] [Related]
6. Host factors affecting perinatal carcinogenesis by resorptive alkylnitrosoureas in rats.
Koestner A; Swenberg JA; Denlinger RH
Natl Cancer Inst Monogr; 1979 May; (51):211-7. PubMed ID: 481574
[TBL] [Abstract][Full Text] [Related]
7. [Transplacental carcinogenesis].
Napalkov NP
Vestn Akad Med Nauk SSSR; 1977; (10):14-9. PubMed ID: 411275
[No Abstract] [Full Text] [Related]
8. Toxicokinetics of bisphenol A in pregnant DA/Han rats after single i.v. application.
Moors S; Diel P; Degen GH
Arch Toxicol; 2006 Oct; 80(10):647-55. PubMed ID: 16604338
[TBL] [Abstract][Full Text] [Related]
9. The contribution of transplacental clearances and fetal clearance to drug disposition in the ovine maternal-fetal unit.
Szeto HH; Umans JG; Rubinow SI
Drug Metab Dispos; 1982; 10(4):382-6. PubMed ID: 6126338
[TBL] [Abstract][Full Text] [Related]
10. Modifying factors in prenatal carcinogenesis (review).
Alexandrov V; Aiello C; Rossi L
In Vivo; 1990; 4(5):327-35. PubMed ID: 2133106
[TBL] [Abstract][Full Text] [Related]
11. Transplacental carcinogenesis.
Mohr U; Emura M; Richter-Reichhelm HB
Invest Cell Pathol; 1980; 3(3):209-29. PubMed ID: 7429882
[No Abstract] [Full Text] [Related]
12. [Transplacental blastomogenesis in mice under conditions of the detoxifying function of the mother's body].
Likhachev AIa; Ivanov-Golitsyn MN
Vopr Onkol; 1976; 22(6):44-7. PubMed ID: 823707
[TBL] [Abstract][Full Text] [Related]
13. [Possibilities for the spread of alpha-fetoprotein and heterologous antibodies in mother and fetus during transplacental carcinogenesis].
Okulov BV; Bobrov IuF
Vopr Onkol; 1975; 21(12):61-5. PubMed ID: 54989
[TBL] [Abstract][Full Text] [Related]
14. Metabolic capabilities of the human fetus: drug biotransformation.
Juchau MR
Addict Dis; 1975; 2(1-2):37-43. PubMed ID: 1163372
[No Abstract] [Full Text] [Related]
15. Metabolism of transplacental carcinogens.
Anderson LM; Jones AB; Miller MS; Chauhan DP
IARC Sci Publ; 1989; (96):155-88. PubMed ID: 2680945
[TBL] [Abstract][Full Text] [Related]
16. Cell sensitivity to transplacental carcinogenesis by N-ethyl-N-nitrosourea is greatest in early post-implantation development.
Donovan PJ
Mutat Res; 1999 Jun; 427(1):59-63. PubMed ID: 10354502
[TBL] [Abstract][Full Text] [Related]
17. Incorporation of transplacental exposure into routine carcinogenicity bioassays.
Swenberg JA
Natl Cancer Inst Monogr; 1979 May; (51):265-8. PubMed ID: 481580
[TBL] [Abstract][Full Text] [Related]
18. Quantitative aspects of transplacental tumor induction with ethylnitrosourea in rats.
Swenberg JA; Koestner A; Wechsler W; Denlinger RH
Cancer Res; 1972 Dec; 32(12):2656-60. PubMed ID: 4345400
[No Abstract] [Full Text] [Related]
19. Carcinogenesis by urethan via mother's milk and its enhancement of transplacental carcinogenesis in mice.
Nomura T
Cancer Res; 1973 Jul; 33(7):1677-83. PubMed ID: 4352796
[No Abstract] [Full Text] [Related]
20. [Transplacental passage of gentamicin and its effect on the fetus].
Nichoga LA; Skosyreva AM; Voropaeva SD
Antibiotiki; 1982 Dec; 27(12):46-50. PubMed ID: 7165294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
